Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:01 PM
Ignite Modification Date:
2025-12-24 @ 7:01 PM
NCT ID:
NCT04323657
Eligibility Criteria:
Inclusion Criteria:
* Patient is \> 18 years of age at the time the Informed Consent is signed
* Patient has agreed to abide by all protocol-required procedures, including study-related assessments, and management by the treating institution for the duration of the study and LTFU
* Histologically confirmed NHL or ALL
* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
* Patient must have adequate organ function as indicated by the laboratory values in the clinical protocol
* Patient must be fit for leukapheresis and have adequate venous access for cell collection
* Patient must have evidence of CD19 expression
* Prior CD19-directed CAR T therapy is allowed
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04323657
Study Brief:
Protocol Section:
NCT04323657